0.00Open0.10Pre Close0 Volume5 Open Interest7.50Strike Price0.00Turnover244.04%IV59.16%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier16DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0239Delta0.0061Gamma181.20Leverage Ratio-0.0157Theta-0.0002Rho-4.32Eff Leverage0.0021Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet